JLE

Epileptic Disorders

MENU

Treatment responsive GABA(B)-receptor limbic encephalitis presenting as new-onset super-refractory status epilepticus (NORSE) in a deployed U.S. soldier Volume 16, numéro 4, December 2014

  • [Berg et al., 2003] Berg D., Holzmann C., Riess O. 14-3-3 Proteins in the nervous system. Nat Rev Neurol. 2003;4:752-762.
  • [Boronat et al., 2011] Boronat A., Sabater L., Saiz A., Dalmau J., Graus F. GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology. 2011;76:795-800.
  • [Costello et al., 2009] Costello D.J., Kilbride R.D., Cole A.J. Cryptogenic new-onset refractory status epilepticus (NORSE) in adults-infectious or not?. J Neurol Sci. 2009;277:26-31.
  • [Höftberger et al., 2013] Höftberger R., Titulaer M.J., Sabater L. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology. 2013;81:1500-1506.
  • [Kim et al., 2014] Kim T.J., Lee S.T., Shin J.W. Clinical manifestations and outcomes of the treatment of patients with GABAB encephalitis. J Neuroimmunol. 2014;270:45-50.
  • [Lancaster et al., 2010] Lancaster E., Lai M., Peng X. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. 2010;9:67-76.
  • [Petit-Pedrol et al., 2014] Petit-Pedrol M., Armangue T., Peng X. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol. 2014;13:276-286.
  • [Rosenfeld and Dalmau, 2011] Rosenfeld M.R., Dalmau J. Anti-NMDA-receptor encephalitis and other synaptic autoimmune disorders. Curr Treat Options Neurol. 2011;13:324-332.
  • [Shorvon, 2011] Shorvon S. Super-refractory status epilepticus: an approach to therapy in this difficult clinical situation. Epilepsia. 2011;52:53-56.